Clinical Trials Browser

Adenocarcinoma Of Esophagus

NCT00628368 2026-02-10

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05051475 2025-10-03

RATE

Phase NA Completed

62 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

NCT06030180 2025-06-27

PR-0410

Phase NA Completed

566 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT03429816 2025-03-27

OPPOSITE

Phase NA Completed

120 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT05069766 2024-02-23

Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences

Phase NA Completed

10 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus

NCT03813381 2023-10-16

CARE-PRO

Phase NA Completed

160 enrolled

GastrointestinalOther

Adenocarcinoma Of Esophagus, Barrett Esophagus, Motor Activity, Obesity, Overweight

NCT04293458 2023-01-25

ESOGUARDBE1

Phase NA Completed

145 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT02560623 2022-11-17

A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus

Phase NA Completed

242 enrolled 13 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

NCT02513784 2022-09-22

Mouthwash

Phase NA Completed

20 enrolled 11 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophagitis, Peptic

NCT02776982 2022-02-09

Influence of Central Obesity on the Esophageal Epithelial Barrier

Phase NA Completed

38 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

NCT04669951 2021-06-03

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Phase NA Completed

100 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma

NCT02890979 2020-11-25

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Phase NA Completed

11 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Barrett Esophagus, Gastroesophageal Reflux, Metaplasia

NCT02100189 2017-05-11

Esophageal Cytology With FISH in Detecting Esophageal Cancer

Phase NA Completed

50 enrolled 9 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Deglutition Disorders, Esophagitis, Gastroesophageal Reflux, Weight Loss

NCT02610764 2017-04-13

ESO-CTC

Phase NA Completed

19 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Neoplastic Cells, Circulating

NCT00004867 2017-01-24

Positron Emission Tomography in Determining Stage of Esophageal Cancer

Phase NA Completed

235 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Clinical Trials

Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

RATE

PR-0410

OPPOSITE

Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences

CARE-PRO

ESOGUARDBE1

A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus

Mouthwash

Influence of Central Obesity on the Esophageal Epithelial Barrier

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Esophageal Cytology With FISH in Detecting Esophageal Cancer

ESO-CTC

Positron Emission Tomography in Determining Stage of Esophageal Cancer